Clinical trials
Phase 4 Hypothyroidism trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 3 |
| 2004 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Unknown status | 8 |
| Terminated | 4 |
| Withdrawn | 2 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shandong Provincial Hospital | 2 |
| Assiut University | 1 |
| Baylor College of Medicine | 1 |
| Bracco Diagnostics, Inc | 1 |
| Children's Mercy Hospital Kansas City | 1 |
| Chinese Academy of Medical Sciences, Fuwai Hospital | 1 |
| Copenhagen University Hospital at Herlev | 1 |
| GE Healthcare | 1 |
| GlaxoSmithKline | 1 |
| Insel Gruppe AG, University Hospital Bern | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypothyroidism | 27 |
| Endocrine System Diseases | 2 |
| Insulin Resistance | 2 |
| Thyroid Diseases | 2 |
| Atherosclerosis | 1 |
| COVID-19 | 1 |
| Celiac Disease | 1 |
| Diabetes Mellitus | 1 |
| Down Syndrome | 1 |
| Fatigue | 1 |
Trials
Showing 51 to 27 of 27. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.